HO CHI MINH CITY, July 1, 2025 /PRNewswire/ -- The Vietnam Career & Training Fair (VCTF) 2025, Vietnam's first professional recruitment and training event,...
VANCOUVER, BC, June 30, 2025 /CNW/ - (TSX: MER) (Nasdaq-Stockholm: MER) – Meren Energy Inc. ("Meren" or the "Company") announces that Mr. John Craig...
OSLO, Norway, June 30, 2025 /PRNewswire/ -- BerGenBio ASA the ("Company") hereby announces a fully underwritten rights issue with preferential subscription rights (the "Subscription...
McCarthy joins Hood following highly successful tenure at Drew University
FREDERICK, Md., June 30, 2025 /PRNewswire/ -- Hood College is pleased to announce the appointment of...
MECHANICSBURG, Pa. and NEW DELHI, June 30, 2025 /PRNewswire/ -- Emerge Education, a leading U.S.-based provider of enrollment, marketing, and international education services, has formed...
SAN DIEGO, June 30, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), have until August 25, 2025 to seek appointment as lead plaintiff of the Sarepta class action lawsuit. Captioned Dolgicer v. Sarepta Therapeutics, Inc., No. 25-cv-05317 (S.D.N.Y.), the Sarepta class action lawsuit charges Sarepta and certain of Sarepta’s top executives with violations of the Securities Exchange Act of 1934.
NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”).
In April, Mark Zuckerberg's ambitious vision for Meta's artificial intelligence initiatives faced a stark reality check. Despite public declarations of an advanced AI model...
COPENHAGEN, Denmark, June 26, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of the first of two clinical trials designed to support approval and use of the MVA-BN® mpox/smallpox vaccine in vulnerable populations: infants under 2 years of age and pregnant and breastfeeding women
ANNECY, France, June 26, 2025 /PRNewswire/ -- The 49th Annecy International Animation Film Festival and Market opened in the summer as scheduled. Chinese animation, with...
PERTH, Western Australia, June 26, 2025 /CNW/ - Westgold Resources Limited (ASX: WGX) (TSX: WGX) – (Westgold or the Company) is pleased to announce it has...